The BU research community have committed themselves to combating the coronavirus since the campus shutdown announced on March 17. Medical students, lab technicians and professors have joined an international movement of private institutions dedicating their resources and expertise to pandemic response.
BUSM’s Center for Regenerative Medicine partnered with the Boston Medical Center to develop a clinically approved in-house test for COVID-19. The test was developed and approved within the span of one week by a group of over 50 volunteer researchers on BU’s Medical Campus, and went into use at BMC March 23.
Members of the Boston University community gathered in the BUild Lab Tuesday evening to view showcases and listen to presentations about the future of certain industries by faculty from departments across BU.
Boston University and the Boston Medical Center received $2.3 million in grants from the Massachusetts Life Sciences Center as part of more than $17 million allocated for capital projects and new equipment...
The Center for Regenerative Medicine at Boston Medical Center and Boston University received a $2.7 million grant on Nov. 6 to construct a stem cell repository that will be open to researchers across...
